Back to results
US 2023/0390194 A1Published application
Formulations of nebivolol
AssigneeNovick Bio Sciences PVT LTD
InventorsVinayak Dinesh DENDUKURI, Rajasekhara Reddy SINGAMPALLI
Life of this patent
Estimating the term…
Abstract
The present disclosure provides a formulation comprising: 0.05 to 10% (w/w) of Nebivolol or a pharmaceutically acceptable salt thereof; 0.4 to 10% (w/w) of a solubilizer; and 5 to 90% (w/w) of a sweetener, wherein the formulation has pH in the range of 3 to 7. The present disclosure provides a reconstituted formulation comprising the formulation with a liquid vehicle. The present disclosure also provides process of preparing the formulations and methods thereof.
Claims18
1-20. (canceled)
An oral liquid formulation comprising:
- a. 0.1 to 2% (w/w) of nebivolol hydrochloride as the sole active ingredient;
- b. 5 to 10% (w/w) of a solubilizer;
- c. 70 to 90% (w/w) of one or more sweetener;
- d. 0.5 to 1% (w/w) of a preservative;
- and
- e. a vehicle selected from the group comprising water, ethyl alcohol, glycerin, syrup and combinations thereof.
3 more elements
Dependencies are inferred from the claim text.